-(1).png?sfvrsn=12aff612_1)
Workshops
All times listed are Eastern Time, unless otherwise noted
AIPLA's popular in-depth skills workshops are back at the Annual Meeting. Workshops offer attendees a chance to learn and engage with instructors in a smaller setting. They are limited in size, so please make sure your experience and interest
aligns with the workshop's requirements and targeted audience. Workshops are limited to 20 people unless noted otherwise, run at the same time as tracks, and attendees will be required to review any materials the instructor has listed as prerequisites. CLE is not offered, and separate
registration is required.
To register use the link on this page.
Thursday, October 30, 10:15 AM - 12:00 PM
In Depth OTDP/Terminal Disclaimers
Strategies for Surviving ODP Post-In re Cellect. Join a dream team of experienced patent practitioners for an in-depth look at a how you can perfect your OTDP practice, including when and how to file a terminal disclaimer.
Instructors: Tom Irving, Marbury Law Group
Julie Burke,
Wan Chieh (Jenny) Lee, Haug Partners
Thursday, October 30, 2:15 - 4:00 PM
Code Scan to Clean Code: Open Source Triage Workshop
This workshop will provide a step-by-step hands-on opportunity to assess the results of a product code scan, and prepare: (i) documentation your hypothetical client needs to comply with the third party software licenses identified by the scan results, and (ii) guidance your client needs to decide whether it should remove certain features, replace third party code, try to negotiate a different license with a third party licensor, or take some other action. As part of this workshop, participants will receive materials they can use in actual remediation projects.
Instructor: Michele Herman, JusTech Law
Ken Corsello, IBM
________________________________________________________________
Navigating the Intersection Between IP and Regulatory Exclusivities for Protecting and Evaluating Pharmaceutical, Biologic, and Medical Device Products
This panel will discuss why IP practitioners should become familiar with regulatory exclusivities and how this knowledge brings value to stakeholders focused on product and business development in the pharmaceutical, biologic, and medical device spaces. Regulatory and patent exclusivity drive significant value during the product development lifecycle and can be critical factors in patent prosecution strategy and in the evaluation of merger and acquisition, licensing opportunities and/or litigation. In the commercialization of medical products, regulatory strategy is often inextricably intertwined with other business and legal topics, such as intellectual property protection and competitive intelligence. This panel will discuss, from both a regulatory and IP perspective, how alignment of strategy can help identify opportunities to leverage exclusivity windows which may be driven by both patent protection, and regulatory submissions. It is important for both private and in-house counsel practitioners (particularly those practicing in patent prosecution, patent litigation, and IP transactions) to understand both the regulatory and patent regimes that provide exclusivity protection for pharmaceutical, biologic, and medical device products to provide more value to clients engaged in product and/or business development in this space.
Instructor: TO COME
Friday, October 31, 10:15 AM - 12:00 PM
Using The Hague Convention for International Design Filings - A Hands-on Program with WIPO
Instructors: TO COME
_________________________________________________________
Trademark Prosecution 101
Instructors: TO COME
Friday, October 31, 2:15 - 4:00 PM
Patent Drafting 101
Instructors: TO COME